Tirzepatide na iya cire fiye da 22 kg a cikin makonni 40. Wani sabon gwaji na bazuwar ya nuna cewa, idan ba a yi horon ƙarfi ba, kusan 4.7 kg na asarar nauyin nan yana daga cikin lean soft tissue (ƙwayar jiki mara mai), kuma ƙarfi ya ragu. Ɗaga nauyi sau uku a mako ya canza wannan hoton.
Gwajin, da aka wallafa a Nature Medicine (online ahead of print, 2026), shine ɗaya daga cikin gwaje‑gwajen ɗan‑Adam mafi bayyane da suka tantance ko motsa jiki na ƙarfi na iya kare lean soft tissue yayin asarar nauyi da aka samu da maganin incretin.
Tsarin Gwaji: Mutane 120, Makonni 40, Magani Guda
Masana a Jami'ar Yammacin Australia da wasu cibiyoyi suka haɗa mutane 120 masu kiba. Kowa ya samu tirzepatide. Daga nan aka raba mahalarta zuwa rassan biyu:
- Tirzepatide kai‑ka‑kai (T): ba tare da horon ƙarfi ba.
- Tirzepatide + horon ƙarfi (T+REx): horon ƙarfi sau uku a mako.
Tsawon lokacin shine makonni 40. An tabbatar da amincin tirzepatide, kuma mafi yawan mahalarta sun ɗauki ƙarin 15 mg a mako, wato mafi girman kashi. Bin diddigin shirin horo ya kai 91 %.
Wannan gwaji ne na ɗan‑Adam na bazuwar, ba gwajin dabbobi ko ƙwayoyin ƙwaya ba. An rijista gwajin (ACTRN12623001236684).
Sakamakon Da Suka Bayyana
Nauyi da asarar kitse: iri ɗaya a duka rassan
- Asarar nauyi: T = -22.61 kg vs T+REx = -22.28 kg (P = 0.694)
- Asarar kitse: T = -17.19 kg vs T+REx = -17.98 kg (P = 0.700)
Bambancin kitse tsakanin rassan ya kasance -0.77 kg (95 % CI -2.14 zuwa 0.60 kg), don haka babu bambanci mai ma’ana.
Lean soft tissue (ƙwayar jiki mara mai): inda horon ƙarfi ya yi tasiri
- Jimillar lean soft tissue: T = -4.67 kg vs T+REx = -3.57 kg (P < 0.001)
- Bambanci tsakanin rassan: 1.09 kg (95 % CI 0.43 zuwa 1.75 kg)
- Lean soft tissue a ƙafafu da hannaye: T = -3.55 kg vs T+REx = -2.92 kg (P < 0.001)
Masu horon ƙarfi ba su ƙara lean soft tissue ba, sai dai sun rasa ƙasa da 1 kg idan aka kwatanta da rukunin da ke amfani da magani kawai. Wannan kusan 25 % ne na raguwar lean soft tissue da ake samu a rukunin magani kadai. Takaitaccen labarin takarda ya bayyana wannan a matsayin "attenuation", kalmar da ta dace.
Ƙarfi: ya ragu a rukunin magani kadai, ya ƙaru da horon ƙarfi
| Gwaji | Tirzepatide kadai (T) | Tirzepatide + REx |
|---|---|---|
| Bench press | -4.09 kg | +4.68 kg |
| Lat pulldown | -4.42 kg | +8.58 kg |
| Knee extension | -4.42 kg | +5.88 kg |
Duk bambance‑bambancen da aka samu idan aka kwatanta da tirzepatide kadai sun kasance masu muhimmanci (P < 0.001). Ba tare da horo ba, ƙarfi a manyan ƙungiyoyi biyu ya ragu. Da horo kuwa, ya tashi a kowane gwaji.
Tsarin Horon: Abin Da Takardar Ta Bayyana
- Yawan lokuta: sau uku a mako
- Tsawon lokaci: makonni 40
- Bin diddigi: 91 %
- Rukunin tsokoki da aka auna: bench press (ƙoƙari na sama), lat pulldown (ja a sama) da knee extension (ƙoƙari na ƙasa)
Ba a bayyana adadin saiti, maimaita, ko nauyin da aka yi amfani da shi ba. Waɗannan cikakkun bayanai suna cikin takarda ta asali, don haka a duba su idan za a tsara shirin horo na musamman. Motsa jiki da aka gwada ya haɗa da push, pull, da ƙafa – wato horo mai cikakken jiki.
Abubuwan Da Za a Iya Aiwatarwa
- Shirya horon ƙarfi sau uku a mako. Wannan shine tsarin da ya haifar da sakamakon, kuma mahalarta sun bi shi kashi 91 % na lokuta.
- Rufe duk jiki. Ƙaruwar ƙarfi ta bayyana a push, pull da ƙafa, don haka shirin cikakken jiki ya fi dacewa.
- Sa ran ceton lean soft tissue, ba lallai ba ne gina sabuwar tsoka. Duka rukuni biyu sun rasa lean soft tissue, amma horon ƙarfi ya rage asarar kusan 1.1 kg.
- Kada ku yi tsammanin horon ƙarfi zai hana asarar kitse. Asarar nauyi da kitse sun kasance kusan iri ɗaya tsakanin rassan.
- Protein. Takardar ba ta ambaci yawan protein ba, don haka ba za a iya fitar da ƙayyadadden shawarwari ba. Ka’idodin abinci na wasanni da na sarcopenia suna ba da shawarar isasshen protein tare da horon ƙarfi. Yi magana da likita ko ƙwararren abinci don tantance adadi.
- Kwayar magani. Mafi yawan mahalarta sun kai 15 mg a mako, amma adadin magani likita ne ke saita, ba gwajin ba. Ɗaga nauyi ƙari ne, ba dalilin canza kwayar ba.
Waɗanda Ya Shafi
Sakamakon sun fi dacewa da manya masu kiba da ke shan tirzepatide (Mounjaro/Zepbound). Rasa lean soft tissue na da muhimmanci musamman ga manya, waɗanda ke da ƙarancin lean soft tissue kuma suna da ƙarin haɗarin rauni da faɗuwa. Takardar ba ta bayar da shekarun mahalarta ba, kuma ba ta yi nazarin ƙungiyoyi daban‑daban na manya ba, don haka ba a tabbatar da cewa sakamakon zai yi aiki ga su ba. Mutane masu cutar haɗin gwiwa, zuciya, ko wasu cututtuka su tattauna da likita kuma su nemi horo daga ƙwararren kafin su fara shirin horon ƙarfi.
Ƙayyadaddun Lura
- "Lean soft tissue" ba tsoka tsantsa ba ce. Yana ƙunshe da ruwa da wasu ƙwayoyin jiki. Ƙaruwar ƙarfi na nuni da fa’idar aiki, amma ba a auna tsoka kai tsaye ba.
- Wasu lean soft tissue har yanzu an rasa. Masu horon ƙarfi sun rasa 3.57 kg na lean soft tissue, don haka horon ƙarfi yana rage asara amma ba ya kawar da ita gaba ɗaya.
- Tsawon lokaci. An bi mahalarta na makonni 40 kacal, kuma abin da zai faru bayan dakatar da magani ko horo ba a bayyana ba.
- Alaka da kamfanoni. Wasu marubuta sun ambaci samun kuɗi daga kamfanonin magani, ciki har da Eli Lilly, wadda ke ƙera tirzepatide. Dukkan kuɗaɗen an tura su zuwa Jami'ar Yammacin Australia. Wani marubuci kuma ɗan hannun jari ne kuma mashawarci ga ProGenis Pharmaceuticals.
Gabaɗaya
Tirzepatide yana haifar da babban asarar nauyi da kitse shi kaɗai, amma kuma yana sa a rasa lean soft tissue da ƙarfi. Ƙara horon ƙarfi sau uku a mako na tsawon makonni 40 ya bar asarar kitse ba tare da canji ba, ya rage asarar lean soft tissue kusan 1.1 kg, kuma ya juya raguwar ƙarfi ya zama ƙaruwa. Ga masu amfani da maganin GLP‑1, wannan gwaji yana nuna cewa ya kamata a haɗa horon ƙarfi a cikin shirin magani. Wannan rubutu na bayanin ne kawai, ba shawara ta likita ba.